# Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals

> **NCT00428519** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 30 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Placebo
- **DRUG:** Aprepitant
- **DRUG:** Aprepitant

## Key facts

- **NCT ID:** NCT00428519
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428519, "Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00428519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*